HTX-100
-
Drug News
NRx Pharmaceuticals Unveils pH-Neutral IV Ketamine Formulation, HTX-100, Revolutionizing Treatment
NRx Pharmaceuticals, Inc. has made a groundbreaking announcement regarding the development of a new, proprietary formulation of intravenous (IV) ketamine,…
Read More »
